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Abstract
Background: There is debate about the role of crude mortality rates and case-mix adjusted
mortality rates in monitoring the outcomes of treatment. In the context of quality improvement a
key purpose of monitoring is to identify special cause variation as this type of variation should be
investigated to identify possible causes. This paper investigates agreement between the
identification of special cause variation in risk adjusted and observed hospital specific mortality
rates after coronary artery bypass grafting in New York hospitals.
Methods: Coronary artery bypass grafting mortality rates between 1994 and 2003 were obtained
from the New York State Department of Health's cardiovascular reports for 41 hospitals. Cross-
sectional control charts of crude (observed) and risk adjusted mortality rates were produced for
each year. Special cause variation was defined as a data point beyond the 99.9% probability limits:
hospitals showing special cause variation were identified for each year. Longitudinal control charts
of crude (observed) and risk adjusted mortality rates were produced for each hospital with data
for all ten years (n = 27). Special cause variation was defined as a data point beyond 99.9%
probability limits, two out of three consecutive data points beyond 95% probability limits (two
standard deviations from the mean) or a run of five consecutive points on one side of the mean.
Years showing special cause variation in mortality were identified for each hospital. Cohen's Kappa
was calculated for agreement between special causes identified in crude and risk-adjusted control
charts.
Results: In cross sectional analysis the Cohen's Kappa was 0.54 (95% confidence interval: 0.28 to
0.78), indicating moderate agreement between the crude and risk-adjusted control charts with
sensitivity 0.4 (95% confidence interval 0.17–0.69) and specificity 0.98 (95% confidence interval:
0.95–0.99). In longitudinal analysis, the Cohen's Kappa was 0.61 (95% confidence interval: 0.39 to
0.83) indicating good agreement between the tests with sensitivity 0.63 (95% confidence interval:
0.39–0.82) and specificity 0.98 (95% confidence interval: 0.96 to 0.99).
Conclusion:  There is moderate-good agreement between signals of special cause variation
between observed and risk-adjusted mortality. Analysis of observed hospital specific CABG
mortality over time and with other hospitals appears to be useful in identifying special causes of
variation. Case-mix adjustment may not be essential for longitudinal monitoring of outcomes using
control charts.
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Background
Monitoring hospital mortality is an integral part of the
quality assurance process in health care provision [1,2].
Mortality rates are often made public and may therefore
be used to rank healthcare providers [3-5]. The ranking
process has been criticised for failing to take sufficient
account of case-mix and failing to distinguish between
variation due to chance and variation due to special
causes [6]. It is generally recommended that mortality
rates be adjusted for measurable case-mix factors [7,8]
However a number of commentators have observed that
adjustment is not without difficulty [9,10]. Others have
debated the advantages of one method of case-mix adjust-
ment over another [11,12]. There is also debate about
whether clinical or administrative data are sufficient for
case-mix adjustment [13,14].
Coefficients used for case-mix adjustment are often
derived on the assumption that there are linear relation-
ships between measurable case-mix factors such as age,
sex, or co-morbidities and outcomes such as mortality. If
the relationships are non-linear, or there are complex
interactions between case-mix factors, or if the relation-
ships change with time, case-mix adjustment may be mis-
leading. Even if there are simple linear relationships
between case-mix factors and mortality, there may also be
systematic associations between case-mix factors and pro-
vider. This would result in confounding, in turn leading to
over or under-adjustment. The issue of un-measurable
case-mix factors presents further challenges to the case-
mix adjustment methodology [15].
Given the difficulties in using adjusted mortality rates it is
worth asking whether analysis of crude mortality rates has
any useful role in delivering quality improvement. Where
monitoring is intended to drive improvement, its princi-
pal aim should be to distinguish between common cause
(chance) variation and special cause variation. Special
cause variation is a signal to guide further investigation
and learn from the results [16,17]. Special cause variation
is identified using charting methods, such as variable life
adjusted displays, cumulative sum charts or Shewhart
control charts [18-20]. Monitoring with the aim of quality
improvement is therefore best undertaken using charts.
The New York State Department of Health's cardiovascu-
lar reports provide a useful data source for exploring our
research question [21]. These reports show observed mor-
tality for all 41 cardiac surgery centres in New York State
during 1994–2003. Using multivariate logistic regression,
each report derives a predicted probability of mortality for
each patient based on measured characteristics such as
age, gender and co-morbidities. Each hospital therefore
has an expected mortality rate: the sum of the predicted
mortalities for its patients. The risk-adjusted mortality is a
comparison of observed to expected numbers of death as
a ratio with confidence intervals to reflect errors to due
random sampling. Finally the reports also cite a risk
adjusted mortality rate: this is the mortality rate that
would be expected in the hospital had its patients been
identical to the state wide mix [21].
A previous simulation study has confirmed that the risk
adjustment methodology in these reports introduced sig-
nificant bias into the calculation of risk adjusted mortality
rates. Nevertheless, varying the case-mix did not appear to
lead to the identification of different statistical outliers
[22]. However this study only looked at outliers in a cross-
sectional analysis of 1996 mortality data. It also defined
outliers as hospitals whose 95% confidence intervals did
not cross a standardized mortality ratio of one.
Shewhart control charts are intended to distinguish
between variation that is consistent with a stable process
(common cause variation) and variation that is not con-
sistent with a stable process (special cause variation). They
are intended to be used as part of a process of quality
improvement. A process that shows common cause varia-
tion will continue to produce the same results. Improve-
ment requires action to change the whole process. Special
cause variation requires investigation to identify the spe-
cial causes that are affecting the process. Special causes
indicate which factors likely to be the most important
influences on the process. This indicates which factors
should be altered to effect improvement. Shewhart con-
trol charts consist of a central line (the mean) and two
lines on either side of this central line (upper and lower
control limits). Data points outside of the control limits
or certain patterns in the data indicate special cause varia-
tion.
This paper investigates the effects of risk adjustment on
the identification of special cause variation in hospital
specific mortality rates after coronary artery bypass graft-
ing in the New York State Department of Health's cardio-
vascular reports.
Methods
Data were obtained from the New York State Department
of Health's cardiovascular reports for the years from 1994
to 2003.
For each year's data cross-sectional P-charts were con-
structed for observed mortality rates and risk-adjusted
mortality rates [23]. Control limits, which were calculated
using an exact method based on the binomial distribu-
tion, were set at 99.9% probability (three standard devia-
tions from the mean), and hospitals with mortality rates
outside of the control limits were identified as indicating
special cause variation. This kind of analysis identifiesBMC Health Services Research 2007, 7:63 http://www.biomedcentral.com/1472-6963/7/63
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whether in any specific year, any individual hospital's
mortality rate shows special cause variation in relation to
other New York hospitals. Cohen's Kappa statistic was cal-
culated for agreement between special cause variation in
observed mortality rate and special cause variation in risk
adjusted mortality rate [24]. In addition, test characteris-
tics (sensitivity and specificity) were calculated, using spe-
cial cause variation in risk-adjusted mortality rate as the
reference standard.
Longitudinal P-charts were constructed for observed mor-
tality rates and risk-adjusted mortality rates within each
hospital over time. The average mortality rate for the hos-
pital over ten years was calculated from the average of all
ten years' data. Exact 99.9% probability control limits
based on the binomial distribution were calculated for
each year from the numbers of cases and numbers of
deaths within the hospital. Special cause variation was
pre-defined as: a single data point outside the 99.9%
probability limits; two out of three successive data points
outside the 95% probability limits (two standard devia-
tions from the mean); five or more successive data points
on one side of the mean (which have probability of ≤ 0.03
of occurring by chance)[25]. Hospitals with incomplete
data (n = 15) were excluded. Longitudinal analysis of this
kind identifies whether any individual hospital's mortal-
ity rate shows special cause variation from its own long-
term mortality rate. The Cohen's Kappa statistic was calcu-
lated for agreement between special cause variation in
observed and risk adjusted mortality rates. Test character-
istics were also calculated, regarding special cause varia-
tion in risk-adjusted mortality as the reference standard.
Longitudinal P-charts were produced for expected mortal-
ity rates in each hospital. Expected mortality rates are a
summary measure of patient case-mix profiles. Longitudi-
nal analysis of this kind identifies whether any individual
hospital's expected mortality rate (and hence its patients'
case-mix profile) shows special cause variation in relation
to its own long-term expected mortality rate. Longitudinal
run charts were also produced for the total number of
cases in each hospital.
Results
Cross-sectional analysis
Figure 1 and Figure 2 show the cross-sectional control
charts for crude and risk-adjusted annual mortality respec-
tively. In the crude cross-sectional charts 11 signals of spe-
cial cause variation (6 low and 5 high) were noted
compared with 10 signals of special cause variation (2 low
and 8 high) from the risk-adjusted charts. Table 1 com-
pares the number of special cause signals from Figure 1
and Figure 2 as a two-by-two table. The associated
Cohen's Kappa statistic is 0.54 (95% confidence interval
0.28–0.78) indicating moderate agreement.
If special cause variation on risk-adjusted mortality is
taken to be the reference standard, the analysis of
observed mortality has a sensitivity of 0.40 (95% confi-
dence interval: 0.17 to 0.69) as a test for special cause var-
iation and a specificity of 0.98 (95% confidence interval:
0.95 to 0.99).
Longitudinal analysis
Figure 3 and Figure 4 show the longitudinal control charts
for crude and risk-adjusted mortality respectively over the
ten year period for all hospitals with complete data (n =
27). In the crude longitudinal control chart there were 14
signals of special cause variation compared with 16 in the
risk-adjusted charts. Table 2 compares the number of spe-
cial cause signals from Figure 3 and Figure 4 as a two-by-
two table. The Kappa statistic is therefore 0.61 (95% con-
fidence interval: 0.39 to 0.83) indicating good agreement
between the tests. If special cause variation on risk-
adjusted mortality is taken to be the reference standard,
the analysis of observed mortality has a sensitivity of 0.63
(95% confidence interval: 0.39 to 0.82) as a test for spe-
cial cause variation in any given year and a specificity of
0.98 (95% confidence interval: 0.96 to 0.99).
Longitudinal analysis of case-mix
There are 12 instances of special cause variation in the 27
longitudinal charts. Eleven of these indicate that the
expected mortality is falling.
Longitudinal analysis of numbers of cases
When all hospitals are combined, from 1994 to 2003
there was a 20% reduction in the number of cases treated.
Discussion
Cross-sectional analysis of crude mortality rates and risk
adjusted mortality rates shows moderate agreement in
identification of special causes for further investigation.
This suggests that when analysing pooled data across dif-
ferent hospitals case-mix adjustment may make a modest
difference to the analysis. Longitudinal analysis of crude
mortality rates and risk adjusted mortality rates shows
good agreement in the identification of special causes. In
particular the specificity of analysis using crude mortality
rates is high, suggesting that few spurious special causes
are likely to be investigated. It is important to note that
our analysis is confined to New York State's reporting of
mortality rates after coronary artery bypass grafting
because these data are publicly available and the general-
isability of our findings should be tested in other settings.
Whilst different stakeholders (public, inspectors, media,
commissioners etc) may use outcome data for different
purposes [15], we believe that the ultimate purpose of
outcome data is to support continual quality improve-
ment. Improvement, by definition, requires action butBMC Health Services Research 2007, 7:63 http://www.biomedcentral.com/1472-6963/7/63
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since not all action leads to improvement, it is important
to have guidance from theory. Shewhart's theory of varia-
tion postulates that outcomes which are consistent with
common cause variation are best addressed by fundamen-
tal changes to the process of care, whereas outcomes
which are consistent with special cause variation require
detective work to find the cause and then action to address
that cause. Outcome monitoring should support these
activities with the ultimate aim of improving quality of
care. Where outcome (case-mix adjusted) monitoring is
used to support judgements about quality of care, often
with rewards and punishments, there are serious risks of
negative consequences such as distortion of data (gam-
ing) and/or distortion of processes of care [15].
Repeated testing with a test that has a high specificity and
a low sensitivity means that true positives (special cause
variation) will eventually be found but few false positives
will be found. Monitoring is an example of repeated test-
ing over time. It is also important to recognise that in the
context of quality improvement finding a single instance
of good practice or bad practice (special cause variation)
is sufficient for an organisation to learn and hence to
improve. It is not necessary to find every instance of good
practice or bad practice (special cause variation). High
sensitivity is therefore not essential to monitoring for
quality improvement. On the other hand investigation of
false positives involves extensive managerial time and
should be avoided, therefore high specificity is important
in monitoring for quality improvement.
It follows from this that longitudinal analysis using
observed (crude), mortality rates may be sufficient to
guide further investigation for internal quality control.
Cross-sectional P-charts of observed (crude) mortality after coronary artery bypass grafting in New York hospitals 1994–2003  for all hospitals Figure 1
Cross-sectional P-charts of observed (crude) mortality after coronary artery bypass grafting in New York hospitals 1994–2003 
for all hospitals. Horizontal line is the mean mortality with exact upper and lower control limits shown as (smoothed) solid 
curves.
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Cross-sectional P-charts of risk-adjusted mortality after coronary artery bypass grafting in New York hospitals 1994–2003 for  all hospitals Figure 2
Cross-sectional P-charts of risk-adjusted mortality after coronary artery bypass grafting in New York hospitals 1994–2003 for 
all hospitals. Horizontal line is the mean mortality with exact upper and lower control limits shown as (smoothed) solid curves.
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Table 1: Cross-sectional analysis: special cause variation in Observed and Risk-Adjusted mortality rates for coronary artery bypass 
grafting surgery 1994 to 2003 in New York hospitals.
Observed mortality rate Risk Adjusted mortality rate
Special cause variation (low) Common cause variation Special cause variation (high) Total
Special cause variation (low) 2 4 0 6
Common cause variation 0 281 6 287
Special cause variation (high) 0 3 2 5
Total 2 288 8 298BMC Health Services Research 2007, 7:63 http://www.biomedcentral.com/1472-6963/7/63
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This is important because calculation of case-mix adjust-
ment factors requires pooling of data from a number of
hospitals which has inherent time delays. Hospitals may
be able to conduct useful internal mortality analysis with-
out external input.
When coupled with the observation that there was, in gen-
eral, a substantial reduction in the number of cases per
hospital and given that the expected mortality rate has
generally fallen, it would suggest that there is some evi-
dence of a tendency for hospitals to select lower risk
patients [26]. The first report on mortality after cardiac
surgery was published in November 1996[21]. Special
cause variation in case-mix generally did not correspond
to special cause variation in observed mortality. On the
one occasion when it did, the hospital also showed special
cause variation after risk-adjustment, indicating that the
case-mix adjustment does not encompass the likely cause
of the variation. The overall impression is that there has
been a change in case-mix over time across the state,
although it is hard to interpret this change in case-mix,
since the multivariate logistic regression equation is recal-
culated each year risk factors and risk factor coefficients
change from one year to the next. For example female gen-
der is considered a risk factor in 1995 to 2002 (Odds
Ratio: 1.426 to 2.097) but not in 1994 or 2003; diabetes
is a risk factor in 1994, 1996, 1998 and 1999 (Odds Ratio:
1.434 to 1.726) but not in 1995, 1997 or from 2000 to
2003.
If referrals are essentially a random sample from a stable
catchment population we would expect variation in case-
Longitudinal P-charts of observed mortality after coronary artery bypass grafting in New York hospitals 1994–2003 for 27 hos- pitals (each panel) Figure 3
Longitudinal P-charts of observed mortality after coronary artery bypass grafting in New York hospitals 1994–2003 for 27 hos-
pitals (each panel). Horizontal line is the mean mortality with exact upper and lower control limits shown as stepped lines 
(solid stepped lines are 99.9% probability limits and dotted stepped lines are 95% probability limits).
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Longitudinal P-charts of risk-adjusted mortality after coronary artery bypass grafting in New York hospitals 1994–2003 for 27  hospitals (each panel) Figure 4
Longitudinal P-charts of risk-adjusted mortality after coronary artery bypass grafting in New York hospitals 1994–2003 for 27 
hospitals (each panel). Horizontal line is the mean mortality with exact upper and lower control limits shown as stepped lines 
(solid stepped lines are 99.9% probability limits and dotted stepped lines are 95% probability limits).
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Table 2: Longitudinal analysis: special cause variation in Observed and Risk-Adjusted mortality rates for coronary artery bypass 
grafting surgery 1994 to 2003 in New York hospitals.
Observed mortality rate Risk Adjusted mortality rate
Special cause variation (low) Common cause variation Special cause variation (high) Total
Special cause variation (low) 6 2 0 8
Common cause variation 0 250 6 256
Special cause variation (high) 0 4 4 8
Total 6 256 10 272BMC Health Services Research 2007, 7:63 http://www.biomedcentral.com/1472-6963/7/63
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mix to be approximately random from year to year. How-
ever coronary artery bypass surgery is an elective proce-
dure. Both patients and their referring physicians
therefore have the opportunity to choose their hospital for
surgery. Surgeons may also be able to exercise choice
about the kinds of patients they prefer to treat. Where elec-
tive procedures are concerned it seems likely that from
year to year within a single hospital there is potential for
non-random variation in case-mix. Despite this, case-mix
rarely changes from one year to the next. When it does
change, case-mix rarely has a great influence on hospital
mortality rates. In comparison, urgent hospital admis-
sions such as those for stroke, myocardial infarction, or
surgery for fractured neck of femur are likely to be unaf-
fected by patient or physician choice. In the absence of
socio-demographic changes in the catchment area, admis-
sion patterns will represent a random sample of the at-risk
population and case-mix is therefore likely to be stable. If
anything, case-mix adjustment from year to year should
be less important in analysis of mortality from urgent pro-
cedures. Indeed, if changes in case-mix are the explana-
tion for special cause variation it may be important for a
hospital to identify and act on this information. It follows
that variation in observed mortality may be just as impor-
tant an outcome to measure. Furthermore, the process of
adjustment for case-mix takes account of some reasons for
variation, but many other important factors (data error,
inputs, processes and care pathways) are unmeasured
[15]. Even if they were measured there are limits to the
data that can be included in a multivariable analysis. Ulti-
mately it is not possible to remove the effects of bias
through adjustment and methods of adjustment based on
logistic regression may increase bias [27].
Conclusion
There is moderate-good agreement between signals of spe-
cial cause variation between observed and risk-adjusted
mortality. Analysis of observed hospital specific CABG
mortality over time and with other hospitals appears to be
useful in identifying special causes of variation. Case-mix
adjustment may not be essential for longitudinal moni-
toring of outcomes using control charts.
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